Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-18-002147
Filing Date
2018-03-15
Accepted
2018-03-15 17:24:28
Documents
14
Period of Report
2018-05-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A pre14a.htm PRE 14A 1304211
2 GRAPHIC pre14ag001.jpg GRAPHIC 25124
3 GRAPHIC pre14ag002.jpg GRAPHIC 3913
4 GRAPHIC pre14ag003.jpg GRAPHIC 3450
5 GRAPHIC pre14ag004.jpg GRAPHIC 19418
6 GRAPHIC pre14ag005.jpg GRAPHIC 17516
7 GRAPHIC pre14ag006.jpg GRAPHIC 16507
8 GRAPHIC pre14ag007.jpg GRAPHIC 12068
9 GRAPHIC pre14ag008.jpg GRAPHIC 74038
10 GRAPHIC pre14ag009.gif GRAPHIC 45618
11 GRAPHIC pre14ag010.gif GRAPHIC 39821
12 GRAPHIC pre14ag011.gif GRAPHIC 71137
13 GRAPHIC pre14ag012.gif GRAPHIC 21682
14 GRAPHIC pre14ag013.gif GRAPHIC 3332
  Complete submission text file 0001558370-18-002147.txt   1793965
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
AxoGen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36046 | Film No.: 18693417
SIC: 3845 Electromedical & Electrotherapeutic Apparatus